Open Access iconOpen Access

ARTICLE

Pivarubicin Is More Effective Than Doxorubicin Against Triple-Negative Breast Cancer In Vivo

Leonard Lothstein*, Judith Soberman, Deanna Parke*, Jatin Gandhi*, Trevor Sweatman, Tiffany Seagroves*

* Department of Pathology and Laboratory Medicine, The University of Tennessee Health Science Center, Memphis, TN, USA
† Department of Medicine, The University of Tennessee Health Science Center, Memphis, TN, USA
‡ Department of Pharmacology, The University of Tennessee Health Science Center, Memphis, TN, USA

TSP_OR_96504020.pdf

  • 644

    View

  • 460

    Download

  • 0

    Like

Share Link